Levy T - Search Results

1

Integration of protein phosphorylation, acetylation, and methylation data sets to outline lung cancer signaling networks.

Grimes M, Hall B, Foltz L, Levy T, Rikova K, Gaiser J, Cook W, Smirnova E, Wheeler T, Clark NR, Lachmann A, Zhang B, Hornbeck P, Ma'ayan A, Comb M. Grimes M, et al. Among authors: levy t. Sci Signal. 2018 May 22;11(531):eaaq1087. doi: 10.1126/scisignal.aaq1087. Sci Signal. 2018. PMID: 29789295 Free PMC article.

2

Quantitative Profiling of Post-translational Modifications by Immunoaffinity Enrichment and LC-MS/MS in Cancer Serum without Immunodepletion.

Gu H, Ren JM, Jia X, Levy T, Rikova K, Yang V, Lee KA, Stokes MP, Silva JC. Gu H, et al. Among authors: levy t. Mol Cell Proteomics. 2016 Feb;15(2):692-702. doi: 10.1074/mcp.O115.052266. Epub 2015 Dec 3. Mol Cell Proteomics. 2016. PMID: 26635363 Free PMC article.

3

PAG1 directs SRC-family kinase intracellular localization to mediate receptor tyrosine kinase-induced differentiation.

Foltz L, Palacios-Moreno J, Mayfield M, Kinch S, Dillon J, Syrenne J, Levy T, Grimes M. Foltz L, et al. Among authors: levy t. Mol Biol Cell. 2020 Sep 15;31(20):2269-2282. doi: 10.1091/mbc.E20-02-0135. Epub 2020 Jul 29. Mol Biol Cell. 2020. PMID: 32726167 Free PMC article.

4

Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication.

Yaron TM, Heaton BE, Levy TM, Johnson JL, Jordan TX, Cohen BM, Kerelsky A, Lin TY, Liberatore KM, Bulaon DK, Van Nest SJ, Koundouros N, Kastenhuber ER, Mercadante MN, Shobana-Ganesh K, He L, Schwartz RE, Chen S, Weinstein H, Elemento O, Piskounova E, Nilsson-Payant BE, Lee G, Trimarco JD, Burke KN, Hamele CE, Chaparian RR, Harding AT, Tata A, Zhu X, Tata PR, Smith CM, Possemato AP, Tkachev SL, Hornbeck PV, Beausoleil SA, Anand SK, Aguet F, Getz G, Davidson AD, Heesom K, Kavanagh-Williamson M, Matthews DA, tenOever BR, Cantley LC, Blenis J, Heaton NS. Yaron TM, et al. Among authors: levy tm. Sci Signal. 2022 Oct 25;15(757):eabm0808. doi: 10.1126/scisignal.abm0808. Epub 2022 Oct 25. Sci Signal. 2022. PMID: 36282911 Free PMC article.

5

Craniofacial chondrogenesis in organoids from human stem cell-derived neural crest cells.

Foltz L, Avabhrath N, Lanchy JM, Levy T, Possemato A, Ariss M, Peterson B, Grimes M. Foltz L, et al. Among authors: levy t. iScience. 2024 Mar 28;27(4):109585. doi: 10.1016/j.isci.2024.109585. eCollection 2024 Apr 19. iScience. 2024. PMID: 38623327 Free PMC article.

6

A multi-purpose, regenerable, proteome-scale, human phosphoserine resource for phosphoproteomics.

Gassaway BM, Li J, Rad R, Mintseris J, Mohler K, Levy T, Aguiar M, Beausoleil SA, Paulo JA, Rinehart J, Huttlin EL, Gygi SP. Gassaway BM, et al. Among authors: levy t. Nat Methods. 2022 Nov;19(11):1371-1375. doi: 10.1038/s41592-022-01638-5. Epub 2022 Oct 24. Nat Methods. 2022. PMID: 36280721 Free PMC article.

7

InTraSeq: A Multimodal Assay that Uncovers New Single-Cell Biology and Regulatory Mechanisms.

Beausoleil S, Ariss M, Huang L, Ding X, Sheth S, Levy T, Fisher J, Loebelenz J, Arlotta K, Dixon K, Polakiewicz R, Kuchroo V. Beausoleil S, et al. Among authors: levy t. Res Sq [Preprint]. 2024 Dec 9:rs.3.rs-5284652. doi: 10.21203/rs.3.rs-5284652/v1. Res Sq. 2024. PMID: 39711533 Free PMC article. Preprint.

8

An open-label study evaluating the safety and efficacy of AMO-01 for the treatment of seizures in Phelan-McDermid syndrome.

Levy T, Holder JL Jr, Horrigan JP, Snape MF, McMorn A, Layton C, Silver H, Friedman K, Grosman H, Underwood S, Halpern D, Zweifach J, Siper PM, Kolevzon A. Levy T, et al. HGG Adv. 2024 Dec 16:100393. doi: 10.1016/j.xhgg.2024.100393. Online ahead of print. HGG Adv. 2024. PMID: 39690738 Free article.

9

Improving Life After Childhood Stroke: Helping Your Child Get the Most Out of Their Home Activity Program to Improve Upper Extremity Function.

Atkinson HL, Vaughn RM, Binkowski A, Casey C, Levy T. Atkinson HL, et al. Among authors: levy t. Arch Phys Med Rehabil. 2024 Dec 9:S0003-9993(24)01352-2. doi: 10.1016/j.apmr.2024.10.019. Online ahead of print. Arch Phys Med Rehabil. 2024. PMID: 39652036 No abstract available.

10

First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial.

Marth C, Moore RG, Bidziński M, Pignata S, Ayhan A, Rubio MJ, Beiner M, Hall M, Vulsteke C, Braicu EI, Sonoda K, Wu X, Frentzas S, Mattar A, Lheureux S, Chen X, Hasegawa K, Magallanes-Maciel M, Choi CH, Shalkova M, Kaen D, Wang PH, Berger R, Okpara CE, McKenzie J, Yao L, Orlowski R, Khemka V, Gilbert L, Makker V; ENGOT-en9/LEAP-001 Investigators. Marth C, et al. J Clin Oncol. 2024 Nov 26:JCO2401326. doi: 10.1200/JCO-24-01326. Online ahead of print. J Clin Oncol. 2024. PMID: 39591551

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

432 results

Search Page

Filters